
H.R. 1, or the Big Beautiful Bill, has brought substantial change to the managed care pharmacy landscape, particularly for managed care organizations (MCOs) with managed Medicaid lines of business.
On Feb. 10, AMCP responded to CMS’s Draft CY 2026 Part D Redesign Program Instructions. The notice, issued on Jan. 10, describes changes to draft guidance for CY 2026 regarding the implementation of section 11201 of the Inflation Reduction Act of 2022.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.